Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Jul 1;349(Pt 1):67–75. doi: 10.1042/0264-6021:3490067

Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy.

M D Parker 1, R J Hyde 1, S Y Yao 1, L McRobert 1, C E Cass 1, J D Young 1, G A McConkey 1, S A Baldwin 1
PMCID: PMC1221121  PMID: 10861212

Abstract

Plasmodium, the aetiologic agent of malaria, cannot synthesize purines de novo, and hence depends upon salvage from the host. Here we describe the molecular cloning and functional expression in Xenopus oocytes of the first purine transporter to be identified in this parasite. This 422-residue protein, which we designate PfENT1, is predicted to contain 11 membrane-spanning segments and is a distantly related member of the widely distributed eukaryotic protein family the equilibrative nucleoside transporters (ENTs). However, it differs profoundly at the sequence and functional levels from its homologous counterparts in the human host. The parasite protein exhibits a broad substrate specificity for natural nucleosides, but transports the purine nucleoside adenosine with a considerably higher apparent affinity (K(m) 0.32+/-0.05 mM) than the pyrimidine nucleoside uridine (K(m) 3.5+/-1.1 mM). It also efficiently transports nucleobases such as adenine (K(m) 0.32+/-0.10 mM) and hypoxanthine (K(m) 0.41+/-0.1 mM), and anti-viral 3'-deoxynucleoside analogues. Moreover, it is not sensitive to classical inhibitors of mammalian ENTs, including NBMPR [6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine, or nitrobenzylthioinosine] and the coronary vasoactive drugs, dipyridamole, dilazep and draflazine. These unique properties suggest that PfENT1 might be a viable target for the development of novel anti-malarial drugs.

Full Text

The Full Text of this article is available as a PDF (283.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin S. A., Mackey J. R., Cass C. E., Young J. D. Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today. 1999 May;5(5):216–224. doi: 10.1016/S1357-4310(99)01459-8. [DOI] [PubMed] [Google Scholar]
  2. Bowman S., Lawson D., Basham D., Brown D., Chillingworth T., Churcher C. M., Craig A., Davies R. M., Devlin K., Feltwell T. The complete nucleotide sequence of chromosome 3 of Plasmodium falciparum. Nature. 1999 Aug 5;400(6744):532–538. doi: 10.1038/22964. [DOI] [PubMed] [Google Scholar]
  3. Carter N. S., Ben Mamoun C., Liu W., Silva E. O., Landfear S. M., Goldberg D. E., Ullman B. Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparum. J Biol Chem. 2000 Apr 7;275(14):10683–10691. doi: 10.1074/jbc.275.14.10683. [DOI] [PubMed] [Google Scholar]
  4. Cass C. E., Young J. D., Baldwin S. A., Cabrita M. A., Graham K. A., Griffiths M., Jennings L. L., Mackey J. R., Ng A. M., Ritzel M. W. Nucleoside transporters of mammalian cells. Pharm Biotechnol. 1999;12:313–352. doi: 10.1007/0-306-46812-3_12. [DOI] [PubMed] [Google Scholar]
  5. Chan T. C., Boon G. D., Shaffer L., Redmond R. Antiviral nucleoside toxicity in canine bone marrow progenitor cells and its relationship to drug permeation. Eur J Haematol. 1992 Aug;49(2):71–76. doi: 10.1111/j.1600-0609.1992.tb00034.x. [DOI] [PubMed] [Google Scholar]
  6. Chan T. C., Shaffer L., Redmond R., Pennington K. L. Permeation and metabolism of anti-HIV and endogenous nucleosides in human immune effector cells. Biochem Pharmacol. 1993 Jul 20;46(2):273–278. doi: 10.1016/0006-2952(93)90414-r. [DOI] [PubMed] [Google Scholar]
  7. Chiang C. W., Carter N., Sullivan W. J., Jr, Donald R. G., Roos D. S., Naguib F. N., el Kouni M. H., Ullman B., Wilson C. M. The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression. J Biol Chem. 1999 Dec 3;274(49):35255–35261. doi: 10.1074/jbc.274.49.35255. [DOI] [PubMed] [Google Scholar]
  8. Crawford C. R., Patel D. H., Naeve C., Belt J. A. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J Biol Chem. 1998 Feb 27;273(9):5288–5293. doi: 10.1074/jbc.273.9.5288. [DOI] [PubMed] [Google Scholar]
  9. Diallinas G., Gorfinkiel L., Arst H. N., Jr, Cecchetto G., Scazzocchio C. Genetic and molecular characterization of a gene encoding a wide specificity purine permease of Aspergillus nidulans reveals a novel family of transporters conserved in prokaryotes and eukaryotes. J Biol Chem. 1995 Apr 14;270(15):8610–8622. doi: 10.1074/jbc.270.15.8610. [DOI] [PubMed] [Google Scholar]
  10. Domin B. A., Mahony W. B., Zimmerman T. P. Membrane permeation mechanisms of 2',3'-dideoxynucleosides. Biochem Pharmacol. 1993 Aug 17;46(4):725–729. doi: 10.1016/0006-2952(93)90560-j. [DOI] [PubMed] [Google Scholar]
  11. Gardner M. J., Tettelin H., Carucci D. J., Cummings L. M., Aravind L., Koonin E. V., Shallom S., Mason T., Yu K., Fujii C. Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science. 1998 Nov 6;282(5391):1126–1132. doi: 10.1126/science.282.5391.1126. [DOI] [PubMed] [Google Scholar]
  12. Gati W. P., Misra H. K., Knaus E. E., Wiebe L. I. Structural modifications at the 2'- and 3'-positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter. Biochem Pharmacol. 1984 Nov 1;33(21):3325–3331. doi: 10.1016/0006-2952(84)90101-1. [DOI] [PubMed] [Google Scholar]
  13. Griffith D. A., Jarvis S. M. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta. 1996 Oct 29;1286(3):153–181. doi: 10.1016/s0304-4157(96)00008-1. [DOI] [PubMed] [Google Scholar]
  14. Huang Q. Q., Harvey C. M., Paterson A. R., Cass C. E., Young J. D. Functional expression of Na(+)-dependent nucleoside transport systems of rat intestine in isolated oocytes of Xenopus laevis. Demonstration that rat jejunum expresses the purine-selective system N1 (cif) and a second, novel system N3 having broad specificity for purine and pyrimidine nucleosides. J Biol Chem. 1993 Sep 25;268(27):20613–20619. [PubMed] [Google Scholar]
  15. Huang Q. Q., Yao S. Y., Ritzel M. W., Paterson A. R., Cass C. E., Young J. D. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J Biol Chem. 1994 Jul 8;269(27):17757–17760. [PubMed] [Google Scholar]
  16. Liman E. R., Tytgat J., Hess P. Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs. Neuron. 1992 Nov;9(5):861–871. doi: 10.1016/0896-6273(92)90239-a. [DOI] [PubMed] [Google Scholar]
  17. Mackey J. R., Baldwin S. A., Young J. D., Cass C. E. Nucleoside transport and its significance for anticancer drug resistance. Drug Resist Updat. 1998;1(5):310–324. doi: 10.1016/s1368-7646(98)80047-2. [DOI] [PubMed] [Google Scholar]
  18. McConkey G. A. Plasmodium falciparum: isolation and characterisation of a gene encoding protozoan GMP synthase. Exp Parasitol. 2000 Jan;94(1):23–32. doi: 10.1006/expr.1999.4467. [DOI] [PubMed] [Google Scholar]
  19. McConkey G. A., Rogers M. J., McCutchan T. F. Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton. J Biol Chem. 1997 Jan 24;272(4):2046–2049. doi: 10.1074/jbc.272.4.2046. [DOI] [PubMed] [Google Scholar]
  20. Mäser P., Sütterlin C., Kralli A., Kaminsky R. A nucleoside transporter from Trypanosoma brucei involved in drug resistance. Science. 1999 Jul 9;285(5425):242–244. doi: 10.1126/science.285.5425.242. [DOI] [PubMed] [Google Scholar]
  21. Osses N., Pearson J. D., Yudilevich D. L., Jarvis S. M. Hypoxanthine enters human vascular endothelial cells (ECV 304) via the nitrobenzylthioinosine-insensitive equilibrative nucleoside transporter. Biochem J. 1996 Aug 1;317(Pt 3):843–848. doi: 10.1042/bj3170843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Penny J. I., Hall S. T., Woodrow C. J., Cowan G. M., Gero A. M., Krishna S. Expression of substrate-specific transporters encoded by Plasmodium falciparum in Xenopus laevis oocytes. Mol Biochem Parasitol. 1998 May 15;93(1):81–89. doi: 10.1016/s0166-6851(98)00024-3. [DOI] [PubMed] [Google Scholar]
  23. Plagemann P. G., Wohlhueter R. M., Woffendin C. Nucleoside and nucleobase transport in animal cells. Biochim Biophys Acta. 1988 Oct 11;947(3):405–443. doi: 10.1016/0304-4157(88)90002-0. [DOI] [PubMed] [Google Scholar]
  24. Sanchez M. A., Ullman B., Landfear S. M., Carter N. S. Cloning and functional expression of a gene encoding a P1 type nucleoside transporter from Trypanosoma brucei. J Biol Chem. 1999 Oct 15;274(42):30244–30249. doi: 10.1074/jbc.274.42.30244. [DOI] [PubMed] [Google Scholar]
  25. Trager W. Cultivation of malaria parasites. Methods Cell Biol. 1994;45:7–26. doi: 10.1016/s0091-679x(08)61844-0. [DOI] [PubMed] [Google Scholar]
  26. Trager W., Jensen J. B. Human malaria parasites in continuous culture. Science. 1976 Aug 20;193(4254):673–675. doi: 10.1126/science.781840. [DOI] [PubMed] [Google Scholar]
  27. Ullman B., Coons T., Rockwell S., McCartan K. Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts. J Biol Chem. 1988 Sep 5;263(25):12391–12396. [PubMed] [Google Scholar]
  28. Vasudevan G., Carter N. S., Drew M. E., Beverley S. M., Sanchez M. A., Seyfang A., Ullman B., Landfear S. M. Cloning of Leishmania nucleoside transporter genes by rescue of a transport-deficient mutant. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9873–9878. doi: 10.1073/pnas.95.17.9873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. White N. J. The treatment of malaria. N Engl J Med. 1996 Sep 12;335(11):800–806. doi: 10.1056/NEJM199609123351107. [DOI] [PubMed] [Google Scholar]
  30. Wirth D. Malaria: a 21st century solution for an ancient disease. Nat Med. 1998 Dec;4(12):1360–1362. doi: 10.1038/3943. [DOI] [PubMed] [Google Scholar]
  31. Woodrow C. J., Penny J. I., Krishna S. Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter. J Biol Chem. 1999 Mar 12;274(11):7272–7277. doi: 10.1074/jbc.274.11.7272. [DOI] [PubMed] [Google Scholar]
  32. Yao S. Y., Ng A. M., Muzyka W. R., Griffiths M., Cass C. E., Baldwin S. A., Young J. D. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem. 1997 Nov 7;272(45):28423–28430. doi: 10.1074/jbc.272.45.28423. [DOI] [PubMed] [Google Scholar]
  33. Zimmerman T. P., Mahony W. B., Prus K. L. 3'-azido-3'-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion. J Biol Chem. 1987 Apr 25;262(12):5748–5754. [PubMed] [Google Scholar]
  34. de Koning H. P., Watson C. J., Jarvis S. M. Characterization of a nucleoside/proton symporter in procyclic Trypanosoma brucei brucei. J Biol Chem. 1998 Apr 17;273(16):9486–9494. doi: 10.1074/jbc.273.16.9486. [DOI] [PubMed] [Google Scholar]
  35. el Kouni M. H., Diop D., O'Shea P., Carlisle R., Sommadossi J. P. Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5'-monophosphate for the treatment of schistosomiasis. Antimicrob Agents Chemother. 1989 Jun;33(6):824–827. doi: 10.1128/aac.33.6.824. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES